Cash, cash equivalents, marketable securities and restricted cash totaled approximately $440 million on June 30, 2024 Biohaven's Molecular Degrader of Extracellular...
Reports
Generali Group reports continued growth in H1 2024 financial results | Insurance Business America Insurance News Generali Group reports continued...
Prudential Financial reports improvements in Q2 2024 results | Insurance Business America Insurance News Prudential Financial reports improvements in Q2...
Company Reports Record Year, With 105% Increase in Reported RevenuesALMATY, KAZAKHSTAN / ACCESSWIRE / June 14, 2024 / Freedom Holding...
Affimed N.V.- Initial data from the LuminICE-203 study shows 85.7% overall response rate (ORR) (6 of 7 patients); 4 out...
